Dexcom Inc (NASDAQ:DXCM)

288.15
Delayed Data
As of May 24
 -35.79 / -11.05%
Today’s Change
282.93
Today|||52-Week Range
659.45
-46.34%
Year-to-Date
Why DexCom Is Down More Than 11% on Tuesday
May 24 / MotleyFool.com - Paid Partner Content
Are Options Traders Betting on a Big Move in DexCom (DXCM) Stock?
May 19 / Zacks.com - Paid Partner Content
Here's Why You Should Hold on to DexCom (DXCM) Stock Now
May 19 / Zacks.com - Paid Partner Content
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
May 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close323.92
Today’s open296.33
Day’s range282.93 - 306.48
Volume2,121,267
Average volume (3 months)845,165
Market cap$31.5B
Data as of 4:00pm ET, 05/24/2022

Growth & Valuation

Earnings growth (last year)-69.40%
Earnings growth (this year)+24.40%
Earnings growth (next 5 years)+42.75%
Revenue growth (last year)+27.08%
P/E ratio150.1
Price/Sales21.95
Price/Book13.84

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.05+0.07%
ZBHZimmer Biomet Holdin...+0.07+0.06%
WSTWest Pharmaceutical ...+0.01+0.00%
SAUHFStraumann Holding AG-1.75-1.47%
Data as of 4:24pm ET, 05/24/2022

Financials

Next reporting dateAugust 2, 2022
EPS forecast (this quarter)$0.75
Annual revenue (last year)$2.4B
Annual profit (last year)$154.7M
Net profit margin6.32%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
San Diego, California

Forecasts